Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020

Hozzl · 2022-02-08T23:22:59Z

Explore the details of Senate Bill 3353 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

2/8/2022, 11:22 PM

Congressional Summary of S 3353

Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020

This bill indefinitely extends Medicare coverage of immunosuppressive drugs for kidney transplant recipients for individuals who do not have other coverage. Under current law, Medicare coverage is limited to 36 months following a transplant.

Additionally, the Government Accountability Office must report on the bill's implementation, including any related program integrity issues.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 3353

Bill S 3353 is currently in the status of Bill Introduced since February 27, 2020. Bill S 3353 was introduced during Congress 116 and was introduced to the Senate on February 27, 2020. Bill S 3353's most recent activity was Read twice and referred to the Committee on Finance. as of February 27, 2020

Bipartisan Support of Bill S 3353

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 3353

Primary Policy Focus

Health

Potential Impact Areas

- Congressional oversight

- Digestive and metabolic diseases

- Drug therapy

- Government studies and investigations

- Health care coverage and access

- Health promotion and preventive care

- Medicare

- Organ and tissue donation and transplantation

- Prescription drugs

Alternate Title(s) of Bill S 3353

Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020

A bill to amend title XVIII of the Social Security Act to provide for extended months of Medicare coverage of immunosuppressive drugs for kidney transplant patients, and for other purposes.